Professor Richard Scolyer recognised in The Pathologist's 2020 Power List.
3 August 2020
The Pathologist reports on research, innovations, personalities, and policies that shape pathology. Each year The Pathologist celebrates 100 inspirational and influential professionals in laboratory medicine.
Professor Scolyer has been recognised in the Big Breakthroughs category, due to his cutting-edge research discoveries that have changed clinical and pathology practice worldwide. He is a leader in determining mechanisms of enhanced response versus resistance to drugs in development, such as immunotherapies – data that underpins the design of current clinical trials.
A world leader in melanoma pathology, Professor Scolyer provides a clinical consultation service for the diagnosis of difficult pigmented lesions, receiving over 2,000 cases from around the world each year.
“My biggest influence has been the Melanoma Institute Australia Research Database that was set up by the late Gerry Milton 60 years ago,” Professor Scolyer says. “This is now the largest melanoma patient database in the world, with over 50,000 patients, and is a major international resource that has provided me with many opportunities to perform important research that correlates pathological and clinical features with patient outcome data in large cohorts.
“Whatever you do, make sure you enjoy the process – because it’s through passion and fulfilment that you will have success and achieve things,”
And Professor Scolyer’s biggest wish? “That people of all ages, but especially young people, were more vigilant in protecting themselves from the sun. UV exposure leading to sunburn is the single biggest risk factor for developing melanoma, which claims one Australian life every five hours.”
See the full 2020 Power List here: https://thepathologist.com/power-list/2020
A message to all Australians from melanoma patient Stuart Taylor
Stuart has advanced melanoma which is not responding to treatment. He has shared his story on ABC's 7:30 in the hope that others can escape the same fate.
Olivia Vivian nominates MIA as Charity Partner on Channel 9's Celebrity Apprentice.
A Ninja Warrior legend and Olympic gymnast, Olivia knows first hand the devastating impact of melanoma.
It's 'Game On Mole' this summer!
All Australians are urged to join the fight against melanoma this summer.
Prof Richard Scolyer named Outstanding Cancer Researcher of the Year
The ground-breaking work of MIA's Co-Medical Director Prof Richard Scolyer has been recognised with NSW’s highest accolade for cancer research.
Dr James Wilmott wins 2020 Wildfire Highly Cited Publication Award
A landmark study led by MIA's Dr Willmott is making a difference to melanoma treatment around the globe.
MIA researchers feature on prestigious Highly Cited Researchers 2020 List
The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe.
Game On Mole is back this summer!
The uniquely Aussie awareness campaign ‘Game On Mole’ is back for its second year – with a new look but same important message.
RCPA recognition for Professor Richard Scolyer.
Professor Richard Scolyer receives The Royal College of Pathologists of Australasia Distinguished Fellow Award.
Professor Georgina Long hands on baton of SMR Presidency
Professor Long cites as a highlight of her 2-year Presidency, the phenomenal research output by SMR members who have continued to lead the cancer field despite the impact of COVID-19.
City2Surf 2020
Join in the fun of the virtual event, and together we can run over melanoma!
Top melanoma experts at MIA
Melanoma Institute Australia features prominently in the latest ‘Expertise in Melanoma’ world rankings, released by Expertscape.
Top melanoma experts from MIA
Melanoma Institute Australia features prominently in the latest ‘Expertise in Melanoma’ world rankings, released by Expertscape.
Melanoma Supportive Care Needs research study.
Participate in our online survey and help us understand the support needs of melanoma patients and carers.
Research reveals long-term benefit of adjuvant therapy for Stage III melanoma
New data reveals long-term benefit of adjuvant therapy for Stage III melanoma.
New online melanoma risk calculators critical to saving lives
Clinicians and their patients now have access to three online risk calculators developed by researchers at Melanoma Institute Australia.
Professor Richard Scolyer receives University of Sydney Alumni Award.
MIA's Co-Medical Director Professor Richard Scolyer has received The University of Sydney Alumni Award for International Achievement.
Uniting together despite the distance
More than 120 MIA clinicians, researchers and staff came together online to share research highlights.
Professor Richard Scolyer recognised in The Pathologist's 2020 Power List.
For the 2nd consecutive year, MIA's Co-Medical Director Professor Richard Scolyer has been selected in the top 100 best, brightest, and most powerful advocates of pathology by The Pathologist.
Important Update: Masks required at Poche Centre
As of Monday 27th July all patients and carers/family members coming into The Poche Centre will be required to bring their own mask.